News | Radiopharmaceuticals and Tracers | November 05, 2022

Alert: Mo-99/Tc-99m Supply Disruptions Possible

The American Society of Nuclear Cardiology has issued an alert about possible supply disruptions

The American Society of Nuclear Cardiology has issued an alert about possible supply disruptions

Getty Images

Nov. 4, 2022 — On October 28, the Nuclear Medicine Europe Emergency Response Team issued a statement about mechanical issues with the BR2 reactor in Belgium and possible Mo-99 supply disruptions through mid- to late-November. 

ASNC has connected with radiopharmaceutical manufacturers to assess their ability to meet the Mo-99 / Tc-99m needs of nuclear cardiology laboratories. Some suppliers have indicated they expect to be able to meet the needs of their regular customers and fulfill some additional demand. Other suppliers have warned that disruptions are likely. 


What Should You Do?

ASNC recommends nuclear cardiology laboratories take the following steps: 

1.    Confirm with your supplier if there will be an interruption in Tc-99m supply.

2.    If so, reschedule patients who are high priority to have their imaging test prior to the supply interruption.

3.    Reschedule less urgent patients to a later date after the Tc-99m supply is expected to be restored.

4.    If necessary, consider alternative testing options based on the principles of PatientFirst Imaging. 


ASNC will continue to monitor the situation. 

For more information:


Related Radioisotope Content:   

NorthStar Medical Radioisotopes Announces Supply Agreement with Aktis Oncology, Inc. for Alpha-Emitting Therapeutic Radioisotope Actinium-225 (Ac-225) 

NorthStar Medical Radioisotopes and Convergent Therapeutics Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)   

Update on HFR Reactor Outage – Medical Isotope Supply Returning to Normal   

Update on Unplanned Outage of the HFR Reactor   

SNMMI Issues Alert That HFR Outage Will Impact Isotope Supply   

NorthStar Medical Radioisotopes Advances Focus on Therapeutic and Specialized SPECT Radiopharmaceuticals   

How Nuclear Fusion is Revolutionizing Medical Isotope Production   

FDA Approves Additional Molybdenum-99 (Mo-99) Filling Lines at NorthStar Medical Radioisotopes   

Medical Isotope Industry Opposes Export of Highly Enriched Uranium for IRE   

IBA and NorthStar Medical Radioisotopes Expand Collaboration to Enable Global Availability of Tc-99m

Related Content

Feature | Molecular Imaging | Dave Fornell, Editor

November 5, 2019 — Philips Medical System is recalling the Forte Gamma Camera System due to the potential for the 660 ...

Home November 05, 2019
Subscribe Now